Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Intranasal Sufentanil vs Ketamine for Severe Acute Trauma Pain in Children
NCT06968546Phase 2Not yet recruiting
- Sponsor
- Fondation Lenval
- Start
- Feb 2026
- Primary completion
- Mar 2028
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of sufentanil in acute pain, sponsored by Fondation Lenval. Planned start Feb 2026; status: not yet recruiting.
02
Drugs
sufentanil
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT06968546.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06968546.